Skip to main content

Peer Review reports

From: Dose of nafamostat mesylate during continuous kidney replacement therapy in critically ill patients: a two-centre observational study

Original Submission
7 Nov 2023 Submitted Original manuscript
23 Nov 2023 Reviewed Reviewer Report
26 Nov 2023 Reviewed Reviewer Report - Lilia Rizo-Topete
3 Dec 2023 Reviewed Reviewer Report - Deepak Bhonagiri
22 Dec 2023 Author responded Author comments - Shinya Kameda
23 Dec 2023 Author responded Author comments - Shinya Kameda
Resubmission - Version 2
22 Dec 2023 Submitted Manuscript version 2
6 Jan 2024 Reviewed Reviewer Report - Deepak Bhonagiri
6 Jan 2024 Reviewed Reviewer Report
24 Jan 2024 Reviewed Reviewer Report - Lilia Rizo-Topete
6 Feb 2024 Author responded Author comments - Shinya Kameda
Resubmission - Version 3
6 Feb 2024 Submitted Manuscript version 3
10 Feb 2024 Author responded Author comments - Shinya Kameda
Resubmission - Version 4
10 Feb 2024 Submitted Manuscript version 4
11 Feb 2024 Author responded Author comments - Shinya Kameda
Resubmission - Version 5
11 Feb 2024 Submitted Manuscript version 5
Publishing
16 Feb 2024 Editorially accepted
26 Feb 2024 Article published 10.1186/s12882-024-03506-0

You can find further information about peer review here.

Back to article page